Metabolites › BMQGVNUXMIRLCK-OAGWZNDDSA-N

cabazitaxel

(2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

BMQGVNUXMIRLCK-OAGWZNDDSA-N CHEBI:63584 0 Reactome links 1 studies
1 Observed studies
1 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
BMQGVNUXMIRLCK-OAGWZNDDSA-N
InChI Key
BMQGVNUXMIRLCK-OAGWZNDDSA-N
IUPAC name
(2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
Preferred name
cabazitaxel
INN name
cabazitaxel
Synonym
—
ChEBI
CHEBI:63584

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles